Cite
HARVARD Citation
Han, K. et al. (n.d.). Simulations to Predict Clinical Trial Outcome of Bevacizumab Plus Chemotherapy vs. Chemotherapy Alone in Patients With First‐Line Gastric Cancer and Elevated Plasma VEGF‐A. CPT: pharmacometrics & systems pharmacology. pp. 352-358. [Online].